9krapalm.com
Blog,
Press release/News aggregator
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English, Thai |
| Country | Thailand |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesInnovative Immunology Biotech Windward Bio Lists on Nasdaq
, /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.
The NYSE Welcomes vVARDIS as a Publicly Listed Company
, /PRNewswire/ — vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities. The NYSE welcomes vVARDIS as a publicly listed company! vVARDIS co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.
Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products
, /PRNewswire/ — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country’s 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings, expanding patient access to treatments for gMG and schizophrenia, and three renewals, which maintain access across oncology and infectious disease.
Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List
, Nov. 14, 2026 /PRNewswire/ — Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabolic, and ophthalmic diseases, announced that seven innovative products of Innovent were successfully included in the updated National Reimbursement Drug List (2026) (the “NRDL”).
Hanoi Emerges as 2026’s Fastest-Growing Solo Travel Destination, Agoda Reports
, /PRNewswire/ — Hanoi recorded the fastest growth in accommodation searches among solo travelers in 2026, with searches rising 22% in the second half of the year, according to digital travel platform Agoda. The finding arrives as 11.11 Singles Day celebrates the joy of doing things independently, from treating yourself to a trip to setting your own itinerary.
WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.
gtinfetch.ai, WeFetch.ai’s lead product, removes the guess from artificial intelligence (AI) shopping: the right barcode, and signed proof of it. , /PRNewswire/ — WeFetch AI Corp., the artificial intelligence (AI) shopping company formerly named GreenCore Solutions Corp., has completed its change of name. The Registrar of Companies for British Columbia issued the Certificate of Change of Name on November 13, 2026. One Answer for Every Barcode An AI agent picks a product in words.
Agoda Matches Five Travel Archetypes with Five Asian Destinations
, /PRNewswire/ — Digital travel platform Agoda outlines five traveler archetypes drawn from its 2027 Asia Travel Pulse, along with the Asian destination that fits each. The survey points to fewer but longer trips, a stronger pull toward food and culture, and growing interest in quieter places and time outdoors. Value also matters, with nearly three in four Asian travelers (73%) planning to spend USD 100 or less per night on accommodation.
Yiren Digital Receives NYSE Notification Regarding Stock Price Requirement
, Nov. 14, 2026 /PRNewswire/ — Yiren Digital Ltd.
Fly-E Group, Inc. Announces Second Quarter and First Half of Fiscal Year 2027 Financial Results
, Nov. 14, 2026 /PRNewswire/ — Fly-E Group, Inc. (Nasdaq: FLYE) (“Fly-E” or the “Company”), an electric vehicle company engaged in designing, installing, selling, and renting smart electric motorcycles, electric bikes, and electric scooters, today announced its unaudited financial results for the second quarter and first half of fiscal year 2027 ended September 30, 2026.
FiEE, Inc. Announces Third Quarter 2026 Unaudited Financial Results
Revenue for the First Nine Months of 2026 Surged 382.1% Year-on-Year to Approximately $9.6 Million Profit Turnaround for the First Nine Months of 2026 with Net Income of $3.6 Million , Nov. 14, 2026 /PRNewswire/ — FiEE, Inc.